| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INZY | Inozyme Pharma, Inc. | Pivotal bioVenture Partners Fund I, L.P. | Director | Aug 01, 2023 | Buy | $4.80 | 833,333 | 3,999,999 | 2,923,110 | Aug 03, 2023, 08:13 PM | |
| INZY | Inozyme Pharma, Inc. | Pivotal bioVenture Partners Fund I, L.P. | Director | Apr 19, 2022 | Buy | $3.69 | 1,070,000 | 3,948,300 | 2,661,154 | Apr 20, 2022, 06:22 PM | |
| INZY | Inozyme Pharma, Inc. | Pivotal bioVenture Partners Fund I, L.P. | 10% Owner | Jul 28, 2020 | Buy | $16.00 | 187,500 | 3,000,000 | 1,591,154 | Jul 28, 2020, 06:15 PM | |
| AKUS | Akouos, Inc. | Pivotal bioVenture Partners Fund I, L.P. | 10% Owner | Jun 30, 2020 | Buy | $17.00 | 294,117 | 4,999,989 | 1,794,088 | Jul 01, 2020, 04:14 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Pivotal bioVenture Partners Fund I, L.P. | 10% Owner | Sep 28, 2018 | Buy | $15.00 | 337,724 | 5,065,860 | 1,180,178 | Oct 02, 2018, 09:39 PM |
Menu